| 04-16-2012 09:22 PM CET - Health & Medicine |
|
FERTINATAL™ DHEA Supplement for Diminished Ovarian Reserve Hits the Market
Press release from: Fertility Nutraceuticals, LLC
(New York, NY) – FERTINATAL™, the first and only dehydroepiandrosterone (DHEA) nutritional supplement designed to enhance female fertility, has entered the market today.
The launch took longer than expected, because Fertility Nutraceuticals, LLC - which developed the supplement - made unusual efforts to ensure that FERTINATAL™ DHEA for women would fulfill all of the required specifications which the product was designed for, with consistency across every tablet, according to Fertility Nutraceuticals. The required repeat rounds of quality-assurance testing at independent laboratories delayed the launch, initially scheduled for January.
“It was extremely frustrating, especially since we have seen increasing demand since we announced FERTINATAL last December,” notes Yu Kizawa, the company’s Director of Marketing and Sales. “Now, we are excited to be able to offer probably the most reliable micronized DHEA product on the market, and the only one specifically designed for women who have a difficult time conceiving.”
FERTINATAL™ was developed with strict adherence to the specifications of the Center for Human Reproduction (CHR, www.centerforhumanreprod.com), a research-driven fertility center in New York City that introduced DHEA supplementation for women with diminished ovarian reserve. Because of the high quality standard of FERTINATAL™, CHR, the only holder of female fertility-related U.S. patents for DHEA supplementation, endorses FERTINATAL™.
“Over-the-counter DHEA products can be very inconsistent in quality, even within the same brand,” explains Norbert Gleicher, MD, medical director of CHR. “Based on the unique quality control process of FERTINATAL™, we are confident that this new product will deliver the kind of consistency and quality we, up to this point, have been able to achieve only through pharmacy-compounded DHEA by prescription. We, therefore, feel confident in endorsing FERTINATAL™.”
FERTINATAL™ is available for purchase at $69.50 per box (a one-month supply), online at www.fertinatal.com.
About Fertility Nutraceuticals, LLC
Fertiltiy Nutraceuticals, LLC, is a company specializing in nutritional supplements for women in reproductive years. The company is dedicated to developing highest-quality nutritional supplements for women with fertility problems, trying to achieve healthy pregnancies. FERTINATAL™ is the company’s first product, with additional products planned for rollout throughout 2012.
Director of Marketing and Sales
Fertility Nutraceuticals, LLC
212-628-0851
info@fertinatal.com
www.fertinatal.com/
Fertility Nutraceuticals, LLC
1015 Madison Avenue #504
New York, NY 10075
USA
This release was published on openPR.
The launch took longer than expected, because Fertility Nutraceuticals, LLC - which developed the supplement - made unusual efforts to ensure that FERTINATAL™ DHEA for women would fulfill all of the required specifications which the product was designed for, with consistency across every tablet, according to Fertility Nutraceuticals. The required repeat rounds of quality-assurance testing at independent laboratories delayed the launch, initially scheduled for January.
“It was extremely frustrating, especially since we have seen increasing demand since we announced FERTINATAL last December,” notes Yu Kizawa, the company’s Director of Marketing and Sales. “Now, we are excited to be able to offer probably the most reliable micronized DHEA product on the market, and the only one specifically designed for women who have a difficult time conceiving.”
FERTINATAL™ was developed with strict adherence to the specifications of the Center for Human Reproduction (CHR, www.centerforhumanreprod.com), a research-driven fertility center in New York City that introduced DHEA supplementation for women with diminished ovarian reserve. Because of the high quality standard of FERTINATAL™, CHR, the only holder of female fertility-related U.S. patents for DHEA supplementation, endorses FERTINATAL™.
“Over-the-counter DHEA products can be very inconsistent in quality, even within the same brand,” explains Norbert Gleicher, MD, medical director of CHR. “Based on the unique quality control process of FERTINATAL™, we are confident that this new product will deliver the kind of consistency and quality we, up to this point, have been able to achieve only through pharmacy-compounded DHEA by prescription. We, therefore, feel confident in endorsing FERTINATAL™.”
FERTINATAL™ is available for purchase at $69.50 per box (a one-month supply), online at www.fertinatal.com.
About Fertility Nutraceuticals, LLC
Fertiltiy Nutraceuticals, LLC, is a company specializing in nutritional supplements for women in reproductive years. The company is dedicated to developing highest-quality nutritional supplements for women with fertility problems, trying to achieve healthy pregnancies. FERTINATAL™ is the company’s first product, with additional products planned for rollout throughout 2012.
Director of Marketing and Sales
Fertility Nutraceuticals, LLC
212-628-0851
info@fertinatal.com
www.fertinatal.com/
Fertility Nutraceuticals, LLC
1015 Madison Avenue #504
New York, NY 10075
USA
This release was published on openPR.
News-ID: 218018
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Fertility Nutraceuticals, LLC
Comments about openPR
Your portal is fast, simple, and easy to use. Others may have more functions but they also demand more editing time, you have to preformat the text in order to achieve a good result etc.
I think openPR is really fantastic!
Andreas Knepper, wallmedien AG
I think openPR is really fantastic!
Andreas Knepper, wallmedien AG


